Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone [clinicaltrials:NCT00960050]
Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone [clinicaltrials:NCT00960050]
Bio2RDF identifier
NCT00960050
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00960050
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Gathering in ...... anemia treated with dapsone.
brief title [clinicaltrials_vocabulary:brief-title]
Methemoglobinemia in Patients ...... ic Anemia Treated With Dapsone
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
Prim ...... c polymorphism
studies.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2009-08-14T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
aplastic anemia
childhood Hodgkin lymphoma
childhood acute lymphoblastic leukemia
childhood acute myeloid leukemia/other myeloid malignancies
childhood anaplastic large cell lymphoma
childhood chronic myelogenous leukemia
childhood diffuse large cell lymphoma
childhood grade III lymphomatoid granulomatosis
childhood immunoblastic large cell lymphoma
childhood large cell lymphoma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2010-05-28T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00960050
official title [clinicaltrials_vocabulary:official-title]
Dapsone Induced Methemoglobinemia Study (DIMS)
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000651820
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2015-05-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
VU-VICC-PED-0937
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2009-06-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2010-05-01T00:00:00Z
identifier
clinicaltrials:NCT00960050
title
Methemoglobinemia in Patients ...... ic Anemia Treated With Dapsone
@en
type
label
Methemoglobinemia in Patients ...... e [clinicaltrials:NCT00960050]
@en